Make Informed Investment Decisions with Affordable Access to Experts
Another View - Understanding Disease Management in Systemic Mastocytosis - A Look at Pipeline Products from Blueprint & DecipheraTicker(s): BPMC, DCPH
Name: Dr Lawrence B. Afrin - MD
Institution: Armonk Integrative Medicine
- Hematologist whose practice now focuses exclusively in mast cell disease.
- Has seen 3000 cases of mast cell disease in the last decade, the vast majority of whom have mast cell activation syndrome (MCAS), with ~2-3% of whom have mastocytosis.
- Has served on national panels on oncology education and MCAS and speaks widely in his areas of focus; has an extensive record of peer-reviewed publications and serves on the editorial boards for several journals and on the Medical Advisory Board for The Mastocytosis Society.
Please describe your clinical practice; roughly how many patients with Systemic mastocytosis do you currently manage?Added By: c_admin
Do you currently prescribe Midostaurin (Rydapt)?Added By: c_admin
What is your current first-line therapy for this disease?Added By: c_admin
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.